Canute Scott A
Insider CIK 1303416 · PRTO Director · FLXN Director · AKBA Director · ONS Director · ONCR Director · IMMU Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCR Oncorus, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 7,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 7,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 9,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 9,000 | $8.50 | $76.5K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-06-24 | 2021-06-28 | 7,000 | — | $0 | 7,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-06-24 | 2021-06-28 | 4,500 | — | $0 | 9,000 | SEC↗ |
| ONCR Oncorus, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONCR Oncorus, Inc. | A Award deriv | 2020-12-11 | 2021-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONCR Oncorus, Inc. | A Award deriv | 2020-12-11 | 2020-12-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 3,718 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 155,286 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer | 2020-10-23 | 2020-10-23 | 13,516 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2020-06-18 | 2020-06-22 | 6,540 | — | $0 | 6,540 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2020-06-18 | 2020-06-22 | 3,718 | — | $0 | 17,234 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-06-10 | 2020-06-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-06-10 | 2020-06-12 | 4,500 | — | $0 | 4,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2019-06-19 | 2019-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-06-07 | 2019-06-11 | 17,077 | — | $0 | 17,077 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2019-06-07 | 2019-06-11 | 9,667 | — | $0 | 13,516 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 13,700 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-03-08 | 2019-03-11 | 22,854 | — | $0 | 22,854 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-03-05 | 2019-03-11 | 79,818 | — | $0 | 79,818 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2018-06-20 | 2018-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2018-06-08 | 2018-06-11 | 12,700 | — | $0 | 12,700 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2018-04-02 | 2018-09-18 | 6,497 | — | $0 | 6,497 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2018-04-02 | 2018-09-18 | 3,849 | — | $0 | 3,849 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2017-10-26 | 2017-10-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2017-07-03 | 2017-07-06 | 22,500 | — | $0 | 22,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2017-06-22 | 2017-07-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2017-06-20 | 2017-06-21 | 6,666 | — | $0 | 6,666 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2016-12-22 | 2016-12-27 | 80,500 | — | $0 | 80,500 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2016-11-28 | 2016-11-30 | 37,315 | — | $0 | 37,315 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other | 2016-11-28 | 2016-11-30 | 57,408 | — | $0 | 246,342 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-11-09 | 2016-11-14 | 57,971 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | M Exercise | 2016-11-09 | 2016-11-14 | 57,971 | — | $0 | 188,934 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-07-29 | 2016-08-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-14 | 6,666 | — | $0 | 6,666 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion deriv | 2016-05-18 | 2016-05-18 | 351 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-05-18 | 2016-05-18 | 58,500 | — | $0 | 130,963 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2015-07-21 | 2015-07-23 | 13,333 | — | $0 | 13,333 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2015-06-17 | 2015-06-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2015-03-04 | 2015-03-06 | 18,000 | — | $0 | 18,000 | SEC↗ |